MOONLAKE IMMUNOTHERAPEUTICS

Ticker: MLTX CUSIP: 61559X104 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 364,000 Value ($000) $4,798 Avg Close $11.80 Range $6.56 - $15.55
Q3 2025
Shares 207,000 Value ($000) $1,484 Avg Close $52.12 Range $5.95 - $62.75
Q2 2025
Shares 45,000 Value ($000) $2,124 Avg Close $40.73 Range $31.42 - $52.88
Q1 2025
Shares 45,000 Value ($000) $1,758 Avg Close $43.09 Range $36.52 - $56.00